Deep learning detection of informative features in tau PET for Alzheimer’s disease classification
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Deep learning detection of informative features in tau PET for Alzheimer’s disease classification ; volume:21 ; number:21 ; day:28 ; month:12 ; year:2020 ; pages:1-13 ; date:12.2020
BMC bioinformatics ; 21, Heft 21 (28.12.2020), 1-13, 12.2020
- Creator
-
Jo, Taeho
Nho, Kwangsik
Risacher, Shannon L.
Saykin, Andrew J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12859-020-03848-0
- URN
-
urn:nbn:de:101:1-2021020118210134135308
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jo, Taeho
- Nho, Kwangsik
- Risacher, Shannon L.
- Saykin, Andrew J.
- SpringerLink (Online service)
Other Objects (12)
CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease